Skip to main content

ACT Advisors, LLC.

SEC CIK
0001842554
Latest filing
Jul 22, 2026

ANTX holding history

AN2 Therapeutics, Inc. in every 13F filed by ACT Advisors, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ANTX overviewAll 13F holders of ANTXFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
1
Since Q3 2025
Holdings of ANTX by ACT Advisors, LLC., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−13,199−100.0%Sold outHolders
Q3 202513,199$16.8K<0.1%+13,199NewHolders